English
You are here: Home » Products » API » Irbinitinib

Product Category

Contact Us
Add: National University Science and Technology Park,zhengzhou city, Henan province

loading

Share to:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Irbinitinib

Irbinitinib is an oral, potent, selective, reversible and ATP-competitive small-molecule inhibitor of ErbB-2 (also called HER2) with IC50s of 8 nM and 7 nM for ErbB-2 and p95 HER2, respectively in cell-based assays, showing ~500-fold selective for HER2 vs EGFR. It has potential antineoplastic activity.
Availability:
Quantity:

Irbinitinib is an oral, potent, selective, reversible and ATP-competitive small-molecule inhibitor of ErbB-2 (also called HER2) with IC50s of 8 nM and 7 nM for ErbB-2 and p95 HER2, respectively in cell-based assays, showing ~500-fold selective for HER2 vs EGFR. It has potential antineoplastic activity.

CAS:937263-43-9

Molecular Formula:C26H24N8O2

Qualifications:GMP Evaluate Report

File:MOA DMF

Standard:In house


Previous: 
Next: 
ONLINE MESSAGE

PRODUCTS

CONTACT US
Add: National University Science and Technology Park,zhengzhou city, Henan province
ONLINE MESSAGE
COPYRIGHT ©KAIFENG MINGREN PHARMACEUTICAL CO.,LTD. ALL RIGHTS RESERVED
TECHNICAL SUPPORT :COVERWEB